|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for credit losses | |||||
| Deferred tax expense/(benefit) | |||||
| Depreciation and amortization | |||||
| Net (gain)/loss on sale of loans held for sale | |||||
| Net loss on available-for-sale debt securities | |||||
| Decrease in valuation allowance on mortgage servicing rights | |||||
| Debt and Equity Securities, Unrealized Gain (Loss) | |||||
| Sales/(purchases) of trading securities, net | |||||
| Stock-based compensation expense | |||||
| Purchases and originations of loans held for sale | |||||
| Proceeds from sales and repayments of loans held for sale | |||||
| Gain on sale of subsidiary | |||||
| Changes in operating assets and liabilities: | |||||
| Accrued interest receivable and other assets | |||||
| Accrued interest payable and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Purchases of available-for-sale debt securities | |||||
| Proceeds from sales of available-for-sale debt securities | |||||
| Proceeds from maturities, redemptions and pay-downs of available-for-sale debt securities | |||||
| Proceeds from maturities, redemptions and pay-downs of held-to-maturity debt securities | |||||
| Sales/(purchases) of equity securities, net | |||||
| Originations of loans held for investment, mortgage finance | |||||
| Proceeds from pay-offs of loans held for investment, mortgage finance | |||||
| Proceeds from sale of mortgage servicing rights | |||||
| Net increase in loans held for investment, excluding mortgage finance loans | |||||
| Proceeds from sale of subsidiary | |||||
| Purchase of premises and equipment, net | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Net increase/(decrease) in deposits | |||||
| Issuance of stock related to stock-based awards | |||||
| Net proceeds from issuance of preferred stock | |||||
| Redemption of preferred stock | |||||
| Preferred stock dividends paid | |||||
| Repurchase of common stock | |||||
| Net increase/(decrease) in short-term borrowings | |||||
| Net proceeds from issuance of long-term debt | |||||
| Redemption of long-term debt | |||||
| Net cash provided by/(used in) financing activities | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid during the period for interest | |||||
| Cash paid during the period for income taxes: | |||||
| Transfers of loans from held for investment to held for sale | |||||
| Transfers of debt securities from available-for-sale to held-to-maturity | |||||
Loading...